Apellis AP2-307--Extension PNH

Clinical Trial Grant

Duke Scholars

Principal Investigator Carlos Manuel de Castro III Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Apellis Pharmaceuticals, Inc

Start Date

February 19, 2020

End Date

May 16, 2025

Awarded By

Apellis Pharmaceuticals, Inc

Start Date

February 19, 2020

End Date

May 16, 2025